DUL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Alnylam Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 110.36 EUR

Market Cap: €12.8B

A	Alnylam Pharmaceuticals Inc XETRA:DUL	US
	Zscaler Inc NASDAQ:ZS	US
	Akron PAO MOEX:AKRN	RU
W	WuXi AppTec Co Ltd F:WX8	CN
J	James Hardie Industries PLC SWB:JHA	IE
L	Lagardere SA DUS:LAG	FR
	Orell Fuessli AG F:OFH	CH
	Ameris Bancorp F:AXU	US
G	Grupa Azoty SA SWB:5PL	PL
R	Rentokil Initial PLC DUS:RTO1	UK
C	Cencora Inc DUS:ABG	US

Profitability Summary

Alnylam Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

84%

Declining Gross Margin

81% > 80%

Healthy Operating Margin

20%

Negative 3Y Average Operating Margin

-1%

Operating Margin is Increasing

-73% > 20%

Healthy Net Margin

17%

Negative 3Y Average Net Margin

-7%

Net Margin is Increasing

-86% > 17%

Exceptional Free Cash Flow Margin

17%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-44% > 17%

Exceptional ROE

101%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.